Global Competent Cells Strategic Business Report 2023:

Dublin, Feb. 03, 2023 (GLOBE NEWSWIRE) -- The "Competent Cells - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

The global market for Competent Cells estimated at US$1.7 Billion in the year 2022, is projected to reach a revised size of US$3.2 Billion by 2030, growing at a CAGR of 8% over the analysis period 2022-2030.

Chemically Competent Cells, one of the segments analyzed in the report, is projected to record 7.3% CAGR and reach US$2.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Electrocompetent Cells segment is readjusted to a revised 9.4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $502.7 Million, While China is Forecast to Grow at 7.5% CAGR

The Competent Cells market in the U.S. is estimated at US$502.7 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$553.3 Million by the year 2030 trailing a CAGR of 7.5% over the analysis period 2022 to 2030.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.2% and 6.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6.2% CAGR.

Select Competitors (Total 46 Featured) -

Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
GenScript Biotech Corporation
Illumina, Inc.
Merck KgaA
New England Biolabs, Inc.
OriGene Technologies, Inc.
Promega Corporation
Qiagen NV
Takara Bio, Inc.
Thermo Fisher Scientific, Inc.
Zymo Research Corporation

What`s New for 2023?

Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
Global competitiveness and key competitor percentage market shares
Market presence across multiple geographies - Strong/Active/Niche/Trivial
Online interactive peer-to-peer collaborative bespoke updates
Access to digital archives and Research Platform
Complimentary updates for one year

Report Attribute	Details
No. of Pages	196
Forecast Period	2022 - 2030
Estimated Market Value (USD) in 2022	$1.7 Billion
Forecasted Market Value (USD) by 2030	$3.2 Billion
Compound Annual Growth Rate	8.2%
Regions Covered	Global

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Influencer Market Insights
World Market Trajectories
Competent Cells - Global Key Competitors Percentage Market Share in 2022 (E)
Competent Cells Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession
Clean-Label Starch Innovations
Chemically Competent Cells Segment Dominate in North America
Drivers & Restrains Summarized for Competent Cells Market
Cloning is Expected to Take the Largest Share of Competent Cells Market
Competent Cells Growth Outlook
Competent Cells Application Trends
Academic and Research Institutes Emerge as Largest End Users of Competent Cells Market
Leading Players in competent cells market

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

Advancements in Molecular Cloning Drives Competent Cell Market
Drivers and Restraints Summarised
SGI-DNA Inc has Launched VmaxT Express Chemically Competent Cells .
Increasing Research on Cloning Demands Competent Cells Requirement
Increasing Intensity of Research and Technological Advancements Drives Market
Expanding Use of Protein Expression in the Production of Therapeutic Proteins Ranging from Insulin, Interferons & Interleukins to Drive Demand for Competent Cells: Global Market for Protein Expression (In US$ Million) for the Years 2017, 2019 & 2022
As the Foundation for Modern Biomolecular Research, Importance of Recombinant Proteins Spurs Demand for Competent Cells
Expanding Use of Protein Expression in the Production of Therapeutic Proteins Ranging from Insulin, Interferons & Interleukins to Drive Demand for Competent Cells: Global Market for Protein Expression (In US$ Million) for the Years 2017, 2019 & 2022
As Molecular Engineering Takes Huge Strides Forward in Manipulating & Harnessing the DNA for the Production of More Potent Therapies, Poised to Benefit are Ready-to-Use Competent Cells
Escherichia coli, the Most Widely Used Organism in the Expression of Cloned Proteins
Need for DNA Library Construction in Molecular Cloning Benefits Demand for Competent Cells
Need for Faster Characterization Proteins & More Efficient Protein Expression Spurs the Use of Competent Cells
Rise of Protein Expression Services Offering Flexible, Low-Cost Production of High-Quality, Bioactive Recombinant Proteins, Bodes Well for Market Growth
Higher Transformation Efficiencies Give Electroporation an Edge Over Chemical Methods
Heat Shock Treatment for Transformation of Competent Cells, Another Popular Method
Increased Investments in Life Sciences Research to Expand the Addressable Market Opportunity for Competent Cells
Rising Global Pharmaceutical R&D Offers a Fertile Environment for the Growth in Demand for Competent Cells: Global Pharmaceutical R&D (In US$ Billion) for the Years 2017, 2019, 2022 and 2024
Continuous Developments in Chemical Transformation Technologies to Benefit Market Growth
Rise in Non-Communicable Diseases, a Key Macro Trend Shaping Demand for Recombinant Enzymes & Proteins in Drug Discovery
Mind Bending Economic Burden of Noncommunicable Diseases (NCDs) Drives Urgent Investments in Drug Research & Development, Opening Up Opportunities for Competent Cells in Mass Production of Therapeutic Proteins: Cumulative Global Burden of NCDs (In US$ Trillion) for the Period 2011-2030
Cell Free Protein Expression & the Accompanying Promise of the Development of a Versatile Mass Production System for Protein Expression to Benefit Market Growth